ELYXYB - CELECOXIB: payments to doctors
Payments that named ELYXYB - CELECOXIB as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $651K
- Providers
- 2,777
- Transactions
- 6,617
- Average per transaction
- $98
The per-transaction average — $98 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,777 providers the average total is $235, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Scilex Pharmaceuticals Inc. | $296,007 | 45.4% |
| Biodelivery Sciences International, Inc. | $275,701 | 42.3% |
| Collegium Pharmaceutical, Inc. | $79,630 | 12.2% |